INC: Exploring the Long-Term Outcomes of High-Dose Oral Riboflavin in Children with Riboflavin Transporter Deficiency
24 ott 2024 ·
2 min. 2 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Inherited Neuropathy Consortium (INC). This summary is based on a paper published in the journal Developmental Medicine and Child Neurology on September 9, 2024, titled "Long-term...
mostra di più
New research from the Inherited Neuropathy Consortium (INC). This summary is based on a paper published in the journal Developmental Medicine and Child Neurology on September 9, 2024, titled "Long-term outcomes in children with riboflavin transporter deficiency and surveillance recommendations."
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16083
Learn more about INC: https://inc.rarediseasesnetwork.org
mostra meno
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16083
Learn more about INC: https://inc.rarediseasesnetwork.org
Informazioni
| Autore | RDCRN |
| Organizzazione | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
